Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
05/1995
05/26/1995WO1995014095A1 Endothelin-converting enzyme
05/26/1995WO1995014085A2 A method for detection of alterations in the dna mismatch repair pathway
05/26/1995WO1995014025A1 Piperidinylcamphorsulfonyl oxytocin antagonists
05/26/1995WO1995014017A1 Non-peptide tachykinin receptor antagonists
05/26/1995WO1995013824A1 Method of treating renal disease by administering igf-i and igfbp-3
05/26/1995WO1995013821A1 αvβ3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS
05/26/1995WO1995013805A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995WO1995013800A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
05/26/1995CA2176819A1 A method for detection of alterations in the dna mismatch repair pathway
05/26/1995CA2176747A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995CA2176735A1 Non-peptide tachykinin receptor antagonists
05/26/1995CA2176727A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
05/26/1995CA2176709A1 Method of treating renal disease by administering igf-i and igfbp-3
05/26/1995CA2176507A1 Endothelin-converting enzyme
05/26/1995CA2174650A1 Piperidinyl camphorsulfonyl oxytocin antagonists
05/24/1995EP0654265A1 Aromatase-inhibiting composition containing azole derivative
05/24/1995EP0654264A1 Treatment of incontinence with venlafaxine or an aryloxy propanamine compound
05/24/1995EP0653937A1 Chemical compounds
05/24/1995EP0447468B1 Ancrod proteins, their production and use
05/23/1995CA1335672C Thioformamide derivatives
05/19/1995CA2118443A1 Aromatase-inhibiting composition containing azole derivative
05/18/1995WO1995013296A1 Receptor specific atrial natriuretic peptides
05/18/1995WO1995013277A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995WO1995013262A1 Substituted phenyl compounds
05/18/1995WO1995013072A1 The use of alfuzosin or terazosin in the treatment of premature ejaculation
05/18/1995WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995CA2176363A1 Substituted phenyl compounds
05/18/1995CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995CA2175897A1 6-oxo-nucleosides useful as immunosuppressants
05/17/1995EP0652903A1 NEW HUMAN RECOMBINANT $g(g) INTERFERON
05/17/1995EP0652868A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF
05/17/1995EP0652749A1 METHODS AND COMPOSITIONS FOR INHIBITING 5$g(a)-REDUCTASE ACTIVITY
05/17/1995CA2135711A1 Cyclic amino acid derivatives
05/16/1995US5416105 Treating an arteriosclerosis with glimepiride
05/16/1995US5416084 Benzo-fused thiomorpholinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/16/1995CA1335569C Agents and procedures for provoking an immune response to gnrh and immuno sterilizing mammals
05/11/1995WO1995012584A1 Novel benzoyl guanidines, their production and their use in medicaments
05/11/1995WO1995012406A1 Use of urinastatin-like compounds to prevent premature delivery
05/11/1995WO1995012398A1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors
05/11/1995WO1995007697A3 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
05/11/1995CA2175838A1 Novel benzoyl guanidines, their production and their use in medicaments
05/11/1995CA2175328A1 Use of urinastatin-like compounds to prevent premature delivery
05/11/1995CA2174234A1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors
05/10/1995EP0652005A1 Methods for inhibiting endometriosis
05/10/1995EP0651999A1 Methods of inhibiting uterine fibrosis
05/10/1995EP0651735A1 Pharmacologically active alpha-(tertiary-aminomethyl)-phenylmethanol derivatives
05/10/1995EP0651641A1 Novel bioactive compositions, preparation and use thereof
05/09/1995US5413998 Benzo-fused thiazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/04/1995WO1995011904A1 Novel a1 adenosine receptor agonists and antiagonists
05/04/1995WO1995011687A1 Therapeutic use of cis-element decoys in vivo
05/03/1995EP0651056A1 Acetyltransferase activity measuring agent
05/03/1995EP0650724A1 Methods for inhibiting uterine fibrosis
05/03/1995EP0650484A1 Endothelin receptor antagonists
05/03/1995EP0456724B1 Composition and method for treating benign prostatic hypertrophy
05/03/1995EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives
05/03/1995CN1102102A Suppository for curing prostatosis
05/02/1995US5412101 Sulphorous derivatives of imidazole, and their use as medicaments and the pharmaceutical compositions containing them
05/02/1995US5411982 Cycloalkylene azoles, and their use as aromatase inhibitors
05/02/1995US5411975 Thiazolidinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411973 Therapeutic alcohols
05/02/1995US5411961 Benzo-fused morpholinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411959 1,4-Thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411954 Benzo-fused oxazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411953 Oxazopinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411950 Benzo-fused oxazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411740 Transdermal administration of oxybutynin
04/1995
04/30/1995CA2117827A1 Acetyltransferase activity measuring agent
04/29/1995CA2134304A1 Methods for inhibiting uterine fibrosis
04/27/1995WO1995011309A2 A novel nuclear mitotic phosphoprotein: mitosin
04/27/1995WO1995011048A2 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO)
04/27/1995CA2173978A1 A novel nuclear mitotic phosphoprotein: mitosin
04/26/1995EP0649654A1 Use of a combination of an ACE-inhibitor with a calcium antagonist in the treatment of proteinuria
04/26/1995EP0649414A1 Opioid diarylmethylpiperazines and piperidines
04/26/1995CN1102040A Quinoline-3-acetic acid derivative, process for producing the same, and use thereof
04/26/1995CN1101908A Angiotensin II antagonists
04/25/1995US5410061 Pharmaceutical compounds
04/25/1995US5409945 Benzyo-fused thiazolidinyl terminated alkylamino ethylnyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409931 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
04/25/1995US5409925 Oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409924 Benzo-fused oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409922 Renin inhibitors
04/25/1995US5409921 Renin inhibitors
04/25/1995US5409913 Oxazocinyl/thiazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409899 Pseudopeptide compounds having anti-inflammatory activity
04/25/1995US5409895 Protease inhibitory polypeptides derived from urinary trypsin inhibitor and compositions thereof
04/25/1995CA1335346C Method of treating erectile dysfunction
04/20/1995WO1995010539A1 Growth differentiation factor-10
04/20/1995WO1995010506A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
04/20/1995WO1995010280A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
04/20/1995WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
04/20/1995WO1995010258A1 Inhibition of urinary calculi growth
04/20/1995CA2171546A1 Growth differentiation factor-10
04/20/1995CA2112871A1 Preparation process of imidazole sulfur derivatives and new intermediate products obtained
04/19/1995EP0648779A2 New 11-benzaldehyde oxime, 17-beta methoxy, 17 alpha methoxymethyl derivates of estradiene, a process for their preparation and pharmaceutical compositions containing them
04/19/1995EP0648778A2 11-Benzaldoximeestradiene-derivates, a process for their preparation and pharmaceutical compositions containing them
04/19/1995EP0648763A1 Process for the preparation of sulfur derivatives of imidazole and intermediates obtained
04/19/1995EP0648758A1 4-Arylamino-benzopyran and related compounds
04/19/1995EP0648208A1 Indole derivatives as testosterone 5 alpha-reductase inhibitors
04/19/1995EP0497915B1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE
04/18/1995US5407956 Hypotensive agents, kidney disorders
1 ... 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 ... 562